美国X 光成像市场规模、份额和趋势分析报告：按应用、规模和细分市场预测，2025 年至 2033 年

美国X射线成像市场趋势：

预计到 2024 年，美国X 光成像市场规模将达到 3.6598 亿美元，2025 年至 2033 年的复合年增长率为 11.95%。

监管措施、医疗保健进步和国家安全优先事项推动着成长。由美国能源局主导的铯辐照器更换计划(CIRP) 为医院、实验室和血液中心提供资金和支持，以非放射性 X 射线系统取代基于铯-137 的设备。癌症、移植手术和免疫力缺乏患者的增加推动了对安全高效的血液辐照技术的需求。此外，美国拥有世界上最大的生物医学研究网络之一，在联邦研究津贴和机构投资的支持下，X 射线辐照器越来越多地用于放射生物学、肿瘤学和临床前应用。 FDA 和 NRC 等机构的严格法律规范使美国在采用创新、安全且合规的 X 射线辐照解决方案方面始终处于领先地位。

医疗设备产业的发展也因企业扩张而进一步得到支持，这反映了市场对非放射性、扩充性灭菌解决方案日益增长的需求，例如 Sterigenics 公司于 2025 年 5 月宣布将在美国东南部开设新的 X 射线灭菌设施。此举凸显了区域内对安全高效的医疗设备灭菌服务日益增长的需求，尤其是在监管审查日益严格、医疗保健提供者和製造商寻求伽马射线和环氧乙烷灭菌方法的替代方案的情况下。此类投资有助于缩短週转时间并降低物流成本，与国家现代化灭菌基础设施和逐步淘汰放射性物质的努力一致，并支持美国在先进 X 射线辐照技术领域的市场领先地位。

随着医疗设备製造商、製药公司和医疗保健提供者寻求更具成本效益和合规性的解决方案，向外包灭菌服务的转变正在推动该行业的显着增长。透过与专门从事灭菌的第三方提供者合作，这些组织可以减少内部基础设施的资本投资，并受益于成熟服务供应商的专业知识、扩充性和监管能力。例如，IBA 与 Steri-Tek 达成协议，将于 2024 年 6 月部署完全整合的 Be Wide X 射线解决方案，这清楚地表明了服务供应商如何扩展其能力以满足不断增长的客户需求。诸如此类的发展显示外包趋势如何推动市场投资和创新。

美国癌症发生率的上升推动了对安全可靠的输血实践和先进研究工具的需求，这些都是 X 光辐照市场的主要驱动力。接受化疗、放射线治疗和骨髓移植的癌症患者的免疫力缺乏严重受损，需要辐照血液成分来预防输血相关移植物抗宿主疾病 (TA-GvHD) 等危及生命的疾病。这导致医院和输血中心采用 X 光血液辐照系统作为铯基系统的安全替代品。此外，美国学术机构和生物製药公司肿瘤学研究的快速增长推动了对用于放射生物学和癌症建模的精密桌上型X光设备的需求。根据美国癌症协会的数据，预计到 2024 年将新增 200 多万例癌症病例，对安全输血通讯协定和专门癌症研究基础设施的需求将继续支持强劲的市场成长。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章美国X 射线曝光市场变数、趋势与范围

• 市场体系展望
  • 补贴市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
  • 市场机会分析
  • 市场问题分析
• 美国X射线辐射市场分析工具
  • 产业分析-波特五力分析
  • PESTEL分析

第四章：美国X光成像市场：应用评估与趋势分析

• 细分仪表板
• 美国X射线成像市场：应用变化分析和市场占有率（2024年和2033年）
• 医疗设备
• 製药
• 生物技术和实验室用品
• 其他的

第五章：美国X光成像市场：规模估计与趋势分析

• 细分仪表板
• 美国X射线成像市场：2024年和2033年规模变化分析和市场占有率
• 小规模
• 中等尺寸
• 大规模

第六章 竞争态势

• 主要市场参与企业的近期趋势和影响分析
• 公司/竞争对手分类
  • 创新者
• 供应商格局
  • 主要经销商和通路合作伙伴名单
  • Key customers
  • Key company market share analysis, 2024
  • STERIS
  • SteriTek, Inc.
  • Sterigenics US, LLC
  • IBA Industrial Solutions
  • E-BEAM Services, Inc
  • KUB Technologies Inc.
  • Precision X-Ray
  • Hopewell Designs, Inc
  • Raycision Medical Technology Co.
  • PTW Freiburg GmbH

U.S. X-ray Irradiation Market Trends:

The U.S. X-ray irradiation market size was valued at USD 365.98 million in 2024 and is expected to grow at a CAGR of 11.95% from 2025 to 2033. The growth is attributed to a combination of regulatory initiatives, healthcare advancements, and national security priorities. A key driver is the Cesium Irradiator Replacement Project (CIRP) led by the U.S. Department of Energy, which provides funding and support for replacing cesium-137-based devices with non-radioactive X-ray systems in hospitals, research labs, and blood centers. The growing prevalence of cancer, transplant procedures, and immunocompromised patient populations has heightened the need for safe, efficient blood irradiation technologies. Moreover, the U.S. hosts one of the world's largest biomedical research networks, where X-ray irradiators are increasingly used for radiobiology, oncology, and preclinical applications, strengthened by federal research grants and institutional investments. With strict regulatory oversight from agencies like the FDA and NRC, the U.S. remains at the forefront of adopting innovative, secure, and compliant X-ray irradiation solutions.

The industry is further propelled by expansions, such as in May 2025, Sterigenics' announcement of new X-ray sterilization capabilities in the Southeast United States, reflecting rising demand for non-radioactive, scalable sterilization solutions. This move underscores the growing need for regional access to safe and efficient medical device sterilization, particularly as healthcare providers and manufacturers seek alternatives to gamma and ethylene oxide methods amid increasing regulatory scrutiny. Such investments support faster turnaround times and reduced logistics costs and align with national efforts to modernize sterilization infrastructure and phase out radioactive materials, supporting the U.S. market's leadership in advanced X-ray irradiation technologies.

The growing shift toward outsourcing sterilization services significantly drives the industry, as medical device manufacturers, pharmaceutical firms, and healthcare providers seek more cost-effective and compliant solutions. By partnering with specialized third-party sterilization providers, these organizations can reduce capital investments in in-house infrastructure and benefit from established service providers' expertise, scalability, and regulatory readiness. For instance, IBA's agreement with Steri-Tek in June 2024 to install a fully integrated Be Wide X-ray solution underscores how service providers are expanding capacity to meet growing client needs. These developments illustrate how outsourcing trends fuel investment and innovation in the market.

The rising prevalence of cancer in the U.S. is a major driver of the X-ray irradiation market, as it increases the demand for safe and reliable blood transfusion practices and advanced research tools. Cancer patients undergoing chemotherapy, radiation therapy, or bone marrow transplants are highly immunocompromised and require irradiated blood components to prevent life-threatening conditions such as Transfusion-associated Graft versus Host Disease (TA-GvHD). This has led to the adoption of X-ray blood irradiators in hospitals and transfusion centers as a safer alternative to cesium-based devices. Additionally, the surge in oncology research across U.S. academic institutions and biopharma companies fuels demand for precise, benchtop X-ray systems used in radiobiology and cancer modeling. According to the American Cancer Society, with over 2 million new cancer cases projected in 2024, the need for safe transfusion protocols and cancer-focused research infrastructure continues to support strong growth in the market.

U.S. X-ray Irradiation Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. X-ray irradiation market report on the basis of application and size:

• Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Medical Devices
  • Pharmaceuticals
  • Biotech & Laboratory Supplies
  • Others
• Size Outlook (Revenue, USD Million, 2021 - 2033)
  • Small-scale
  • Mid-scale
  • Large-scale

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Purchased database.
• 1.5. GVR's internal database
• 1.6. Secondary sources
• 1.7. Third Party Perspective
• 1.8. Primary research
• 1.9. Details of primary research
• 1.10. Information or Data Analysis
• 1.11. Data analysis models
• 1.12. Market Formulation & Validation
• 1.13. Model Details
• 1.14. Commodity flow analysis (Model 1)
  • 1.14.1. Approach 1: Commodity flow approach
• 1.15. Volume price analysis (Model 2)
  • 1.15.1. Approach 2: Volume price analysis
• 1.16. List of Secondary Sources
• 1.17. List of Primary Sources
• 1.18. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. X-ray Irradiation Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Shift away from radioisotopes
    • 3.2.1.2. Rising healthcare demands
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High initial investment
    • 3.2.2.2. Limited awareness in developing regions
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Growing biotech and research applications
  • 3.2.4. Market Challenges Analysis
    • 3.2.4.1. Competition from E-beam and gamma irradiation
• 3.3. U.S. X-ray Irradiation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. X-ray Irradiation Market: Application Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. X-ray Irradiation Market: Application Movement Analysis & Market Share, 2024 & 2033
• 4.3. Medical Devices
  • 4.3.1. Medical Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Pharmaceuticals
  • 4.4.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Biotech & Laboratory Supplies
  • 4.5.1. Biotech & Laboratory Supplies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Others
  • 4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. X-ray Irradiation Market: Size Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. X-ray Irradiation Market: Size Movement Analysis & Market Share, 2024 & 2033
• 5.3. Small-scale
  • 5.3.1. Small-scale Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Mid-scale
  • 5.4.1. Mid-scale Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 5.5. Large-scale
  • 5.5.1. Large-scale Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
  • 6.2.1. Innovators
• 6.3. Vendor Landscape
  • 6.3.1. List of key distributors and channel partners
  • 6.3.2. Key customers
  • 6.3.3. Key company market share analysis, 2024
  • 6.3.4. STERIS
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Product benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. SteriTek, Inc.
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Product benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. Sterigenics U.S., LLC
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Product benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. IBA Industrial Solutions
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Product benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. E-BEAM Services, Inc
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Product benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. KUB Technologies Inc.
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Product benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. Precision X-Ray
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Product benchmarking
    • 6.3.10.4. Strategic initiatives
  • 6.3.11. Hopewell Designs, Inc
    • 6.3.11.1. Company overview
    • 6.3.11.2. Financial performance
    • 6.3.11.3. Product benchmarking
    • 6.3.11.4. Strategic initiatives
  • 6.3.12. Raycision Medical Technology Co.
    • 6.3.12.1. Company overview
    • 6.3.12.2. Financial performance
    • 6.3.12.3. Product benchmarking
    • 6.3.12.4. Strategic initiatives
  • 6.3.13. PTW Freiburg GmbH
    • 6.3.13.1. Company overview
    • 6.3.13.2. Financial performance
    • 6.3.13.3. Product benchmarking
    • 6.3.13.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. X-ray irradiation market, by application, 2021 - 2033 (USD Million)
• Table 4 U.S. X-ray irradiation market, by size, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Automated medical washer disinfector market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2024)
• Fig. 10 Segment outlook
• Fig. 11 Strategy framework
• Fig. 12 Penetration & growth prospect mapping
• Fig. 13 Consumer behavior analysis
• Fig. 14 Market driver relevance analysis (Current & future impact)
• Fig. 15 Market restraint relevance analysis (Current & future impact)
• Fig. 16 Porter's Five Forces analysis
• Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 18 Medical devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 19 Pharmaceuticals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 20 Biotech & laboratory supplies mastectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 21 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 22 Small-scale market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 23 Mid-scale market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 24 Large-scale market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 25 Company market share analysis, 2024
• Fig. 26 Market differentiators